III Capital Management’s Exact Sciences EXAS Stock Holding History

III Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-32,300	Closed	-$2.99M	–	64
2019 Q4	$2.99M	Buy	+32,300	New	+$2.84M	1.52%	20

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

III Capital Management's EXAS Position: Q1 2020 in Review

III Capital Management sold out of Exact Sciences (EXAS) in Q1 2020, closing a stake of 32,300 shares — an estimated $2.99M sold.

III Capital Management first reported a position in EXAS in Q4 2019 and held it in 1 quarter. The position peaked at $2.99M in Q4 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

III Capital Management reported no remaining Exact Sciences position as of Q1 2020 after selling out during the quarter.
III Capital Management sold 32,300 Exact Sciences shares in Q1 2020, an estimated $2.99M.
III Capital Management first reported a position in Exact Sciences in Q4 2019 and held it in 1 quarter.
III Capital Management's Exact Sciences position peaked at $2.99M in Q4 2019.
475 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on III Capital Management's 13F filing for Q1 2020, filed 14 May 2020.